Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.91 is 59% below its 5-year average of 7.14, near the low end of its 5-year range (1.27–25.29).
As of the fiscal period ended Tuesday, June 30, 2026. 2.77% below its 12-month average of 2.99.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.91.
CURRENT RATIO
2.91
CURRENT RATIO AVG TTM
2.99
CURRENT RATIO AVG 3Y
6.57
CURRENT RATIO AVG 5Y
7.14
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-2.77%
CURRENT VS 3Y AVG
-55.69%
CURRENT VS 5Y AVG
-59.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-22.36%
vs the sector median at left
Werewolf Therapeutics, Inc.
Market Cap
$44.88M
Current Ratio
2.91
TTM Avg
2.99
3Y Avg
6.57
5Y Avg
7.14
Market Cap
$43.23M
Current Ratio
2.55
TTM Avg
3.96
3Y Avg
5.38
5Y Avg
6.26
Market Cap
$42.38M
Current Ratio
0.98
TTM Avg
2.74
3Y Avg
1.63
5Y Avg
1.13
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $44.88M | 2.91 | 2.99 | 6.57 | 7.14 |
| DarioHealth Corp. (DRIO)vs › | $44.97M | 2.31 | 3.08 | 3.34 | 3.56 |
| Celularity Inc. (CELU)vs › | $45.73M | 0.09 | 0.27 | 0.34 | 1.05 |
| SANUWAVE Health Inc. (SNWV)vs › | $43.92M | 1.28 | 0.90 | 0.52 | 0.40 |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.23M | 2.55 | 3.96 | 5.38 | 6.26 |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.81M | 2.84 | 4.79 | 4.65 | 11.57 |
| CVRx, Inc. (CVRX)vs › | $42.46M | 8.04 | 9.85 | 12.28 | 13.79 |
| BioStem Technologies, Inc. (BSEM)vs › | $42.38M | 0.98 | 2.74 | 1.63 | 1.13 |
| Instil Bio, Inc. (TIL)vs › | $47.41M | 21.67 | 27.64 | 19.68 | 18.08 |
| Lite Strategy, Inc. (LITS)vs › | $47.47M | 5.74 | 9.62 | 7.35 | 7.40 |
Current Ratio
2.91
Quick Ratio
2.91
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.91 |
| 2026-03-31 | 1.27 |
| 2025-12-31 | 1.62 |
| 2025-09-30 | 3.87 |
| 2025-06-30 | 5.30 |
| 2025-03-31 | 8.09 |
| 2024-12-31 | 7.45 |
| 2024-09-30 | 10.10 |
| 2024-06-30 | 12.13 |
| 2024-03-31 | 6.71 |
| 2023-12-31 | 7.14 |
| 2023-09-30 | 9.01 |
| 2023-06-30 | 9.82 |
| 2023-03-31 | 7.21 |
| 2022-12-31 | 5.84 |
| 2022-09-30 | 5.45 |
| 2022-06-30 | 5.08 |
| 2022-03-31 | 13.19 |
| 2021-12-31 | 13.56 |
| 2021-09-30 | 22.43 |
| 2021-06-30 | 25.29 |
| 2021-03-31 | 15.69 |
| 2020-12-31 | 17.58 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
